Silco Pharmaceuticals Limited (SILCOPHL)
B
| Pharmaceuticals & Chemicals
INTRADAY 1MIN CHART
Loading ...
Price: -
Volume: -
Today Analysis
Silco Pharmaceuticals Limited এর শেয়ারটি 15.20 BDT-এ লেনদেন হচ্ছে, যা বর্তমান ট্রেন্ডে পতনের দিকে। কোম্পানিটির NAV 23.02 BDT-এ অবস্থান করছে, যা দীর্ঘমেয়াদী বিনিয়োগের জন্য একটি নির্দেশক হিসেবে কাজ করে। কোম্পানির P/E Ratio নির্দেশ করে এটি তুলনামূলকভাবে আয়ের চেয়ে কতগুণ বেশি মূল্যে লেনদেন হচ্ছে। টেকনিক্যাল এনালাইসিস অনুযায়ী, সাপোর্ট লেভেল 14.74 BDT-এর কাছাকাছি হতে পারে, যেখানে শেয়ারটি ঘুরে দাঁড়াতে পারে। অন্যদিকে 15.73 BDT-এ একটি সম্ভাব্য রেজিস্ট্যান্স আছে, যেখানে দাম বাধা পেতে পারে। বিনিয়োগের সিদ্ধান্ত নেওয়ার আগে, মার্কেটের সামগ্রিক অবস্থা ও কোম্পানির ফান্ডামেন্টালগুলো বিবেচনা করা জরুরি।
(Disclaimer: This system generated summary is for informational purposes only and does not constitute financial advice.)
Market Depth (Live Order Book)
Buy Orders (Bids)
| Cum Qty | Volume | Price |
|---|---|---|
| No buy orders | ||
Sell Orders (Asks)
| Price | Volume | Cum Qty |
|---|---|---|
| No sell orders | ||
| Date | Close | Volume | Trade | Change | Ch(%) | Open | High | Low |
|---|---|---|---|---|---|---|---|---|
| Loading historical data... | ||||||||
04 May, 2026
SILCOPHL: Transmission of Deceased Sponsor's Shares to Nominee
The Company has informed that Dr. Md. Afzal Miah, one of the Sponsors of the Company, passed away on 02.08.2025. His entire holding of 110,000 shares of the Company will be transmitted to the account of his nominee, Md. Ashfaque Hussain Suhag (son of Late Dr. Md. Afzal Miah) by way of nomination.
30 Apr, 2026
SILCOPHL: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.05 for January-March 2026 as against Tk. 0.13 for January-March 2025; EPS was Tk. 0.32 for July 2025-March 2026 as against Tk. 0.40 for July 2024-March 2025. NOCFPS was Tk. 0.67 for July 2025-March 2026 as against Tk. 0.71 for July 2024-March 2025. NAV per share was Tk. 23.27 as on March 31, 2026 and Tk. 23.02 as on June 30, 2025.
23 Apr, 2026
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.
11 Mar, 2026
SILCOPHL: Category Change
The Company has been placed in 'B' category from existing 'Z' category with effect from today i.e., March 11, 2026 as the Company has reported disbursement of 1.10% Cash Dividend for the year ended June 30, 2025.
03 Mar, 2026
SILCOPHL: Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase securities of Silco Pharmaceuticals Limited with effect from today i.e., March 03, 2026 as per rule 11(8) of Bangladesh Securities and Exchange Commission (Margin) Rules, 2025.
03 Mar, 2026
SILCOPHL: Category Change
The Company has been placed in 'Z' category from existing 'B' category with effect from today i.e., March 03, 2026 as per provision 1(e) of BSEC Directive No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024 regarding non-disbursement of the approved dividend within the stipulated time frame.
01 Feb, 2026
SILCOPHL: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.11 for October-December 2025 as against Tk. 0.10 for October-December 2024; EPS was Tk. 0.27 for July-December 2025 as against Tk. 0.27 for July-December 2024. NOCFPS was Tk. 0.51 for July-December 2025 as against Tk. 0.62 for July-December 2024. NAV per share was Tk. 23.29 as on December 31, 2025 and Tk. 23.02 as on June 30, 2025.
26 Jan, 2026
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.
23 Dec, 2025
SILCOPHL: Emphasis of Matters
The auditor of the company has given the Emphasis of Matters paragraph in the audited financial statements of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Silco%20Pharmaceuticals%20Limited_2025.pdf
15 Dec, 2025
SILCOPHL: Resumption after Record Date
Trading of the shares of the company will resume on 17.12.2025.
14 Dec, 2025
SILCOPHL: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 15.12.2025.
10 Dec, 2025
SILCOPHL: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 11.12.2025 to 14.12.2025 and trading of the shares will remain suspended on record date i.e., 15.12.2025.
01 Dec, 2025
SILCOPHL: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.16 for July-September 2025 as against Tk. 0.17 for July-September 2024. NOCFPS was Tk. 0.27 for July-September 2025 as against Tk. 0.24 for July-September 2024. NAV per share was Tk. 23.18 as on September 30, 2025 and Tk. 23.02 as on June 30, 2025.
25 Nov, 2025
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 30, 2025 at 3:30 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
18 Nov, 2025
SILCOPHL: Update of Information
The company has requested the shareholders to check and update their respective BO ID's, Bank A/c details along with routing number to get dividend online through BEFTN system. The company has also requested to provide 12 digits e-TIN to BO A/c and get Tax deduction @ 10% instead of 15%.
18 Nov, 2025
SILCOPHL: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (18.11.2025) following its corporate declaration.
18 Nov, 2025
SILCOPHL: Dividend Declaration
The Board of Directors has recommended 1.10% Cash Dividend for all shareholders excluding Directors for the year ended June 30, 2025. The Directors hold 36,615,370 shares out of the total 103,807,000 shares of the company and Cash Dividend payable to the General Shareholders, Independent Directors and Sponsors only is Tk. 7,391,079.00 for 67,191,630 shares. (cont.)
11 Nov, 2025
SILCOPHL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 17, 2025 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
22 Jul, 2025
SILCOPHL: Transmission of Deceased Sponsor Director's shares to his nominee
Prof. Dr. Azizur Rahman, one of the Sponsor Directors of the company, passed away on 12.05.2025. The company has informed that his holding of 3,317,457 shares will be transmitted to the account of his nominee Ms. Rowshan Ara Chowdhury, who is wife of Prof. Dr. Azizur Rahman.
29 Apr, 2025
SILCOPHL: Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.13 for January-March 2025 as against Tk. 0.16 for January-March 2024; EPS was Tk. 0.40 for July 2024-March 2025 as against Tk. 0.39 for July 2023-March 2024. NOCFPS was Tk. 0.71 for July 2024-March 2025 as against Tk. 0.68 for July 2023-March 2024. NAV per share was Tk. 23.01 as on March 31, 2025 and Tk. 22.66 as on June 30, 2024.
20 Apr, 2025
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
24 Feb, 2025
SILCOPHL: Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
02 Feb, 2025
SILCOPHL: Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.10 for October-December 2024 as against Tk. 0.12 for October-December 2023; EPS was Tk. 0.27 for July-December 2024 as against Tk. 0.23 for July-December 2023. NOCFPS was Tk. 0.62 for July-December 2024 as against Tk. 0.37 for July-December 2023. NAV per share was Tk. 22.94 as on December 31, 2024 and Tk. 22.66 as on June 30, 2024.
27 Jan, 2025
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
30 Dec, 2024
SILCOPHL: Credit Rating Result
Alpha Credit Rating PLC (Alpha Rating) has assigned the Initial rating of the Company as "BBB" in the long term and "ST-3" in the short term along with Stable outlook based on the audited financial statements as on June 30, 2023 and relevant qualitative information till December 28, 2024.
08 Dec, 2024
SILCOPHL: Resumption after Record date
Trading of the shares of the company will resume on 09.12.2024.
05 Dec, 2024
SILCOPHL: Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 08.12.2024.
03 Dec, 2024
SILCOPHL: Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 04.12.2024 to 05.12.2024 and trading of the shares will remain suspended on record date i.e., 08.12.2024.
24 Nov, 2024
SILCOPHL: Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.17 for July-September 2024 as against Tk. 0.11 for July-September 2023; NOCFPS was Tk. 0.24 for July-September 2024 as against Tk. 0.16 for July-September 2023. NAV per share was Tk. 22.84 as on September 30, 2024 and Tk. 22.66 as on June 30, 2024.
17 Nov, 2024
SILCOPHL: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 21, 2024 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
03 Nov, 2024
SILCOPHL: Price Limit Open
There will be no price limit on the trading of the shares of the Company today (03.11.2024) following its corporate declaration.
03 Nov, 2024
SILCOPHL: Dividend Declaration
The Board of Directors has recommended 1% cash dividend for all shareholders excluding Directors for the year ended June 30, 2024. The Directors hold 4,02,78,370 shares out of total 10,38,07,000 shares of the Company and the cash dividend to be payable to the General shareholders, Independent Directors and Sponsors is Tk. 6,352,863.00. (cont.)
24 Oct, 2024
SILCOPHL: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 31, 2024 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
Total Records: 7 Years
| Year | Type | Cash(%) | Stock(%) | EPS | NAV | Remarks |
|---|---|---|---|---|---|---|
| 2025 | Final | 1.10% | - | 0.41 | 23.02 | 18-Nov-2025 |
| 2024 | Final | 1.00% | - | 0.44 | 22.66 | 03-Nov-2024 |
| 2023 | Final | 3.00% | - | 0.67 | 22.35 | 27-Nov-2023 |
| 2022 | Final | 5.00% | - | 0.81 | 21.95 | 06-Nov-2022 |
| 2021 | Final | 10.00% | - | 0.82 | 21.85 | 24-Nov-2021 |
| 2020 | Annual | 10.00% | - | 0.80 | 21.64 | 02-Nov-2020 |
| 2019 | Annual | 2.00% | 10.00% | 2.28 | 23.12 | 27-Oct-2019 |
30-Day Block Transactions
| Date | Max Price | Min Price | Trades | Quantity | Value (Mn) |
|---|---|---|---|---|---|
| 2026-09-21 | 20.10 | 20.10 | 1 | 25,100 | 0.505 |
| 2026-09-08 | 18.60 | 18.60 | 1 | 27,500 | 0.511 |
Company Info
Trading Code
SILCOPHL
Category : Sector
A : Pharmaceuticals & Chemicals
NAV
23.02 Tk.
P/E Audited
42.68
Paid up Capital
1,038.07 crore
Authorized Capital
1,050.00 crore
Market Capital
1,733.58 crore
Total Securities
103,807,000
Reserve & Surplus
1,351.81 crore
Website
http://www.silcopharma.com/
Current Shareholding
Public Holding: 5.02 Cr unit
Public: 48.39% (5.02 Cr unit)
Director: 35.27% (3.66 Cr unit)
Institute: 16.34% (1.70 Cr unit)
Foreign: 0.00% (0.00 Cr unit)
Govt: 0.00% (0.00 Cr unit)
EPS History
NAV History
Dividend History
Cash Dividend
Stock Dividend
Historical Monthly Performance
Compare cumulative monthly performance.
Best Month
-
Worst Month
-
Avg MoM
-
Positive
-
Positive Yrs
-
Historical Insight
-
Historical Seasonality
Holding Period Returns
Entry → Exit Analysis
Entry Month:
Select an entry month to view historical holding period outcomes.
* Historical performance is not indicative of future results. Historical calculations are based on past closing prices and do not constitute investment advice. Dividends are not included.
| Period Ending: |
2021
07/10/2026
|
2022
07/10/2026
|
2023
07/10/2026
|
2024
07/10/2026
|
2025
07/10/2026
|
|---|---|---|---|---|---|
| Total Revenues | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Gross Profit | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Expenses | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Operating Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Pre-tax Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Income | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EBITDA | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| EPS (Basic) | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash & Equivalents | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Assets | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Current Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Liabilities | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Debt | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Total Equity | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Operations | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Investing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Cash from Financing | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Capital Expenditure | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Free Cash Flow | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
| Net Change in Cash | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 | 123,456.00 |
Unlock Full Financial Data
Upgrade to PRO to access complete historical financial statements, quarterly reports, and deep fundamental analysis.
Upgrade to PROSilco Pharmaceuticals Limited
B | Pharmaceuticals & Chemicals
Today-
15 dys-
30 dys-
3 mths-
6 mths-
1 yr-
LTP:-
Open:-
High:-
Low:-
YCP:-
Vol:-
52W H:-
52W L:-
Crct Lw:-
Circuit Up:-
Value:-
M. Cap:-
P/E (Un/A):-
EPS:-
NAV:-
Paid-up:-
Ttl Share:-
Yr end:-
Reserve:-
ROE:-
EPS Q2-
EPS Q3-
EPS ANN-
EPS Q1-
DIV-
DIV YIELD-
Last AGM: -
Record Date: -
Shareholding
(as on -)
Public
0%
Director
0%
Institute
0%
Foreign
0%
Govt.
0%
Market Overview
Loading Data...
(%)
Day Open
Total Trade
Day High
Total Volume
Day Low
Value (Cr)
MARKET STATUS
Up
Down
Unchanged
All Instruments
| Symbol | LTP | Chg% |
|---|---|---|
| Loading... | ||
Sectors
| Sector | Chg% |
|---|---|
| Loading... | |
Stock Screener
Quick Screens
| Symbol | LTP | PE |
|---|---|---|
| Run filter to see results | ||
Alerts
Favorites
Watchlists
Portfolio
My Screeners
| Symbol | LTP | PE |
|---|
Run filter to see results
Market Movers
| # | Symbol | LTP | Chg% |
|---|---|---|---|
| Loading... | |||
AI Insights
Business Pro user exclusive
Login to see